A detailed history of Concentric Capital Strategies, LP transactions in Johnson & Johnson stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 6,042 shares of JNJ stock, worth $956,086. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,042
Holding current value
$956,086
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $872,343 - $953,306
6,042 New
6,042 $883,000
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $508,991 - $570,200
3,268 New
3,268 $508,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $414B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.